GENinCode plc
FINPROM Findings
10“The Issue Price represents a discount of approximately 47.4 per cent. to the mid-market closing price of an Ordinary Share on 20 January 2026”
47.4% discount to last close. Retail is offered shares at less than half the prevailing market price alongside a £3.5m placing — aggressive retail targeting and material dilution risk.
“"The Board remains confident in the Company's commercial progress... looks forward to scaling revenue growth while reducing losses, aiming for breakeven and profitability over the medium term"”
Optimistic forward-looking statement about path to profitability from a pre-profit company that admits it may have insufficient capital to continue trading. The juxtaposition of 'confident' language with the going concern warning creates a mixed message.
“"minimum subscription of £50 per investor" ... "available to both existing shareholders and new investors" ... "from tax efficient savings vehicles such as ISAs or SIPPs" ... "No commission will be charged" ... "sign up here"”
Very low minimum subscription threshold (£50) combined with open targeting to new investors, ISA/SIPP promotion, no-commission messaging, and sign-up CTA. For a company disclosing potential inability to continue trading in the companion RNS, this level of retail accessibility is an area for improvement.
“fund the completion of its US regulatory and reimbursement program whilst driving commercialisation in the US, expanding its activities in the UK and Europe whilst positioning the Company on a pathway to breakeven/profitability over the medium term”
The retail offer RNS includes a forward-looking statement about achieving 'breakeven/profitability over the medium term' within the use-of-proceeds section visible to retail investors. While a forward-looking statements disclaimer exists at the end, this specific claim in the body text is presented without immediate qualification and could influence retail subscription decisions.
“"in light of the Group's low cash position, it would be likely that the Company would have insufficient capital to be able to continue trading"”
The announcement explicitly states the company would likely have insufficient capital to continue trading without the fundraise. This is a clear going concern / distress indicator, and the company is simultaneously launching a retail offer to the public. [Adjusted: strong institutional demand supplemented the retail component.]
“None of RetailBook or any of its affiliates, accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to this announcement”
RetailBook approves the announcement as a financial promotion under s.21 FSMA yet simultaneously disclaims all liability for the announcement's contents. While legally standard, the juxtaposition of being the s.21 approver while disclaiming responsibility for the content may create ambiguity about the platform's actual role and accountability in the offer process.
“conditionally raised gross proceeds of £4.0 million (before expenses) through the issue of an aggregate of 108,108,108 New Ordinary Shares ... Enlarged Share Capital following Admission”
The placing and subscription issue 108m new shares against an existing share capital of approximately 176m shares (directors held ~8.3% pre-raise), representing significant dilution of circa 61%. While the discount of 5.1% is modest, the dilution quantum is material. Director percentage holdings fall notably (e.g. Puig from 8.3% to 4.9%), though the retail offer is capped at only £500k additional.
“"THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION... APPROVED BY RETAIL BOOK LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FCA (FRN 994238). THIS FINANCIAL PROMOTION IS NOT INTENDED TO BE INVESTMENT ADVICE."”
Correctly identifies as a financial promotion, names the approving FCA-authorised firm, and includes appropriate disclaimers.
“Certain of the Company's Directors have either themselves or through parties affiliated with them subscribed for an aggregate of 4,662,162 New Ordinary Shares at the Issue Price as part of the Subscription”
Director participation in the placing is disclosed transparently with a detailed table showing each director's existing and new holdings, including beneficial ownership through affiliates. This is good disclosure practice. Director participation amounts are modest relative to the total raise (c.£172k of £4m), which is not concerning.
“The Placing is not subject to clawback from the Retail Offer”
The result announcement clearly states the placing is not subject to retail clawback, providing certainty to institutional placees and transparency to retail investors about allocation mechanics. This is helpful disclosure for both investor cohorts.
RNS Announcements
6Result of Retail Offer
THIS ANNOUNCEMENT. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF THE LAWS OF ENGLAND AND WALES PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN. 26 January 2026 GENinCode Plc (" GENinCode " or the " Company ") Result of WRAP Retail Offer GENinCode (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease a…
Retail Offer
THIS ANNOUNCEMENT. THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY WINTERFLOOD SECURITIES LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 141455). 21 January 2026 GENinCode Plc (" GENinCode " or the " Company ") WRAP Retail Offer for up to £500,000 GENinCode Plc (AIM: GENI), the genetics company focused on the prevention of cardiovascular disease (" CVD ") and the early detection of ovarian cancer, is pleased to ann…
Result of Retail Offer
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN. …
Placing and Subscription
THIS ANNOUNCEMENT, INCLUDING THE APPENDICES, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL (TOGETHER THE "RESTRICTED JURISDICTIONS" AND EACH BEING A "RESTRICTED JURISDICTION"). PLEASE SEE THE IMPORTANT NOTICE IN APPENDIX II TO THIS ANNOUNCEMENT. THIS ANNOUNCEMENT, INCLUDING THE APPENDICES, IS FOR INFORMAT…
Result of Placing and Subscription
THIS ANNOUNCEMENT. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY UK MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFOR…
Retail Offer
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE…
Board of Directors
20| Name | Role | Appointed | Status |
|---|---|---|---|
| Felix Wilhelm Frueh | Director | 2022-04-01 | active |
| Jordi Puig Gilberte | Director | 2018-09-06 | active |
| Matthew Heaton Walls | Executive Director | 2018-09-06 | active |
| Paul Andrew Peter Foulger | Director | 2021-04-01 | active |
| Paul Foulger | Director | 2021-07-16 | active |
| Professor Huon Hamilton Gray | Director | 2022-02-21 | active |
| Sergio Olivero | Director | 2020-05-01 | active |
| William Edward Rhodes | Non-Executive Director | 2021-01-01 | active |
| Matthew Heaton Walls | Executive Director | 2018-09-06 | active |
| William Edward Rhodes | Non-Executive Director | 2021-01-01 | active |
| Felix Wilhelm Frueh | director | 2022-04-01 | active |
| Jordi Puig Gilberte | director | 2018-09-06 | active |
| Paul Andrew Peter Foulger | director | 2021-07-16 | active |
| Paul Foulger | secretary | 2021-07-16 | active |
| Professor Huon Hamilton Gray | director | 2022-02-21 | active |
| Sergio Olivero | director | 2020-05-01 | active |
| Stella Panu | director | 2021-04-18 | active |
| Andrew Bryant Symmonds | director | 2020-07-31 | active |
| Jeremy Curnock Cook | director | 2020-07-31 | active |
| David Eric Evans | director | 2020-05-01 | active |